RBR-8rv93wn尚未招募1 期
Evaluation of the use of Cannabidiol in Third Molar Extraction Surgeries
niversidade Federal de Uberlândia0 个研究点开始时间: 2023年10月17日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18Y 至 60Y（—）
入选标准
- •Patients of both genders. aged between 18 and 60 years. who are systemically healthy and who require surgery to remove the four third molars
排除标准
- •Patients using drugs acting on the central nervous system. decompensated diabetics (glycated hemoglobin above 8%). consumption of any medication 15 days prior to inclusion in this study, patients with hypersensitivity to the drugs to be used in postoperative care, pregnant women or during lactation. chronic smokers and alcoholics. presence of periapical lesions. presence of pericoronitis lesions
研究者
相似试验
招募中
3 期
Evaluation of the effect of cannabidiol in the treatment of dystoniaDystoniaIRCT20211019052811N1Mashhad University of Medical Sciences60
尚未招募
3 期
Canabidiol (CBD) for Treatment of Frontal Lobe EpilepsyTreatment Resistant Epilepsy.Epilepsy and recurrent seizuresIRCT20210608051515N1Tehran University of Medical Sciences30
招募中
不适用
Cannabidiol enhancement of exposure therapy in patients with phobias.Phobic anxiety disorders, fobische angststoornissenNL-OMON28305trecht University72
进行中（未招募）
不适用
Does adding cannabidiol (a component of cannabis) enhance the treatment of phobias where patients are confronted with their fears (exposure treatment).EUCTR2014-004094-17-NLniversiteit Utrecht
已完成
3 期
Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias.Phobic anxiety disorders10002861NL-OMON44760niversiteit Utrecht72